Search the webpage

Director In Vivo Pharmacology. Location: Headquarters, Kuopio, Finland.

Director In Vivo Pharmacology. Location: Headquarters, Kuopio, Finland.

ABOUT

Dr. Cerrada-Gimenez obtained his PhD in Biotechnology from the A.I. Virtanen Institute at the University of Eastern Finland in 2011. Shortly thereafter, Marc joined Charles River Discovery Services (Kuopio, Finland), where he led the Biomarker and in vitro team designing and leading multiple projects, which aimed at studying various neurodegenerative indications.

In 2016, he joined the biotech Minoryx Therapeutics as Head of Biomarker Discovery collaborating in the development of compounds for the treatment of rare diseases, with the most advanced candidate currently undergoing Phase II-III. During that time he acquired experience in the preparation and submission of regulatory documents for the EMA and FDA.

FOLLOW

CONTACT ME BY EMAIL

Marc Gimenez

LATEST NEWS

Experimentica Ltd. appoints new Director of Business Development

News
Kuopio, Finland, 27th January 2019: Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Guillaume ... Read More

Professional Development Programme at Experimentica in 2020

News
We are delighted to announce that professional development of our talented employees in 2020 will be co-funded by the European ... Read More

Meet us at SMi’s Ophthalmic Drugs Conference 2019 in London, UK, 2019

News
We are pleased to be a part of the 3rd Annual Ophthalmic Drugs Conference and Focus Day, taking place on ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!